CALL/VERTEX PHARMACEUTICALS/700/0.1/20.09.24 Share Price

Warrant

DE000GG2SER9

Real-time BOERSE MUENCHEN 08:08:42 29/05/2024 BST
0.045 EUR -23.73% Intraday chart for CALL/VERTEX PHARMACEUTICALS/700/0.1/20.09.24
Current month+118.52%
1 month+156.52%
Date Price Change
29/05/24 0.045 -23.73%
28/05/24 0.059 +40.48%
27/05/24 0.042 +5.00%
24/05/24 0.04 +33.33%
23/05/24 0.03 -3.23%

Real-time BOERSE MUENCHEN

Last update May 29, 2024 at 08:08 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying VERTEX PHARMACEUTICALS INCORPORATED
Issuer Goldman Sachs
WKN GG2SER
ISINDE000GG2SER9
Date issued 18/01/2024
Strike 700 $
Maturity 20/09/2024 (115 Days)
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.253
Lowest since issue 0.008
Spread 0.3
Spread %83.33%

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
More about the company

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Vertex Pharmaceuticals Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
446.9 USD
Average target price
462.8 USD
Spread / Average Target
+3.57%
Consensus